iBio Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Stockholders' Equity - Issuances of Common Stock (Details)

Stockholders' Equity - Issuances of Common Stock (Details)											12 Months Ended		24 Months Ended
	Jan. 29, 2025 USD ($) shares	Jan. 10, 2025 USD ($) $ / shares shares	Apr. 01, 2024 USD ($)	Mar. 26, 2024 USD ($) $ / shares shares	Dec. 07, 2023 USD ($) $ / shares shares	Aug. 11, 2023 USD ($) $ / shares shares	Dec. 09, 2022 shares	Dec. 06, 2022 shares	Nov. 01, 2021 $ / shares shares	Nov. 25, 2020 USD ($) shares	Jun. 30, 2025 USD ($) $ / shares shares	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2024 $ / shares shares	Jul. 03, 2024 USD ($) $ / shares	Aug. 04, 2023 $ / shares shares	Aug. 03, 2023 $ / shares
Class of Stock [Line Items]
Common stock, par value \| $ / shares											$ 0.001
Preferred stock, shares issued											0
Combined price per share of common stock and warrants \| $ / shares											$ 0.76	$ 2.11	$ 2.11
Proceeds from the exercise of stock options \| $											$ 131,000
Subscription receivable \| $											$ 105,000
Restricted Stock Units
Class of Stock [Line Items]
Shares vested											35,369	42,054
Employee Stock Option
Class of Stock [Line Items]
Shares exercised											73,100	0	0
Weighted-average exercise price \| $ / shares											$ 3.2	$ 1.92
Proceeds from the exercise of stock options \| $											$ 130,550
Maximum \| Employee Stock Option
Class of Stock [Line Items]
Weighted-average exercise price \| $ / shares											$ 2.45
Minimum \| Employee Stock Option
Class of Stock [Line Items]
Weighted-average exercise price \| $ / shares											$ 1.72
Cantor Fitzgerald Underwriting \| At-The-Market Offerings \| Common Stock
Class of Stock [Line Items]
Common stock, shares issued										460,133	0	170,989
Gross proceeds from sale of equity \| $										$ 8,100,000
Net proceeds from sale of equity \| $												$ 1,700,000
Cantor Fitzgerald Underwriting \| At-The-Market Offerings \| Common Stock \| Maximum
Class of Stock [Line Items]
Aggregate offering price \| $										$ 100,000,000
Wainwright Underwriting \| At-The-Market Offerings
Class of Stock [Line Items]
Agent fee percentage							7.00%
Wainwright Underwriting \| At-The-Market Offerings \| Common Stock
Class of Stock [Line Items]
Common stock, shares issued								76,538
Wainwright Underwriting \| At-The-Market Offerings \| Common Stock \| Pre-Funded Warrants
Class of Stock [Line Items]
Warrants, shares issued								91,730
Wainwright Underwriting \| At-The-Market Offerings \| Common Stock \| Series A warrants
Class of Stock [Line Items]
Warrants, shares issued								168,267
Wainwright Underwriting \| At-The-Market Offerings \| Common Stock \| Series B warrants
Class of Stock [Line Items]
Warrants, shares issued								168,267
Wainwright Underwriting \| H.C. Wainwright & Co. \| Underwriters Option \| Common Stock
Class of Stock [Line Items]
Underwriters purchase option period							30 days
Wainwright Underwriting \| H.C. Wainwright & Co. \| Underwriters Option \| Common Stock \| Maximum
Class of Stock [Line Items]
Warrants, shares issued							50,480
Wainwright Underwriting \| H.C. Wainwright & Co. \| Underwriters Option \| Common Stock \| Minimum
Class of Stock [Line Items]
Common stock, shares issued							25,240
Wainwright Underwriting \| H.C. Wainwright & Co. \| Underwriters Option \| Common Stock \| Representative Warrants
Class of Stock [Line Items]
Warrants, shares issued							10,094
Additional shares for purchase, percentage of aggregate shares in offerings							6.00%
Wainwright Underwriting \| H.C. Wainwright & Co. \| Underwriters Option \| Common Stock \| Series A warrants
Class of Stock [Line Items]
Warrants, shares issued							25,240
Wainwright Underwriting \| H.C. Wainwright & Co. \| Underwriters Option \| Common Stock \| Series B warrants
Class of Stock [Line Items]
Warrants, shares issued							25,240
Lincoln Park Stock Purchase Agreement \| At-The-Market Offerings \| Common Stock
Class of Stock [Line Items]
Aggregate offering price \| $						$ 10,000,000
Common stock, shares issued												202,595
Gross proceeds from sale of equity \| $						$ 5,000,000
Net proceeds from sale of equity \| $												$ 1,300,000
Common stock, shares available for future issuance											0
Term of stock purchase agreement						24 months
Initial commitment shares issued						10,573
Additional commitment shares issued						10,573
Lincoln Park Stock Purchase Agreement \| At-The-Market Offerings \| Common Stock \| Maximum
Class of Stock [Line Items]
Aggregate offering price \| $						$ 10,000,000
Shares available for purchase when stock price closes between $3 and $20 per share						5,000
Shares available for purchase when stock price closes between $20 and $40 per share						7,500
Shares available for purchase when stock price closes at or above $40 per share						10,000
Fair value of common stock purchased in single transaction \| $						$ 500,000
Lincoln Park Stock Purchase Agreement \| At-The-Market Offerings \| Common Stock \| Minimum
Class of Stock [Line Items]
Stock price permitting the sale of up to 5,000 shares \| $ / shares						$ 3
Stock price permitting the sale of up to 7,500 shares \| $ / shares						20
Stock price permitting the sale of up to 10,000 shares \| $ / shares						40
Stock price permitting accelerated purchase clause \| $ / shares						$ 4
Number of "additional accelerated purchases" that may be directed						1
Securities Purchase Agreement \| Alliance Global Partners \| Private placement
Class of Stock [Line Items]
Net proceeds from sale of equity \| $					$ 4,000,000
Combined price per share of common stock and warrants \| $ / shares					$ 2
Reimbursement for legal expenses \| $					$ 75,000
Non-accountable expense allowance \| $					$ 15,000
Accrued stock issuance costs \| $											$ 308,000
Agent fee percentage					5.50%
Securities Purchase Agreement \| Alliance Global Partners \| Private placement \| Common Stock
Class of Stock [Line Items]
Common stock, shares issued					600,000
Securities Purchase Agreement \| Alliance Global Partners \| Private placement \| Common Stock \| Pre-Funded Warrants
Class of Stock [Line Items]
Warrants, shares issued					1,650,000
Warrants, shares of common stock issuable upon conversion					1,650,000
Securities Purchase Agreement \| Alliance Global Partners \| Private placement \| Common Stock \| Series C Warrants
Class of Stock [Line Items]
Warrants, shares issued					2,250,000
Warrants, shares of common stock issuable upon conversion					2,250,000
Securities Purchase Agreement \| Alliance Global Partners \| Private placement \| Common Stock \| Series D Warrants
Class of Stock [Line Items]
Warrants, shares issued					2,250,000
Warrants, shares of common stock issuable upon conversion					2,250,000
Securities Purchase Agreement and Warrants \| Private placement
Class of Stock [Line Items]
Gross proceeds from sale of equity \| $				$ 15,100,000
Reimbursement for legal expenses \| $			$ 50,000
Agent fee percentage			6.00%
Reduced placement agent fee percentage			4.00%
Securities Purchase Agreement and Warrants \| Private placement \| Common Stock
Class of Stock [Line Items]
Common stock, shares issued				2,701,315
Net proceeds from sale of equity \| $			$ 14,100,000
Securities Purchase Agreement and Warrants \| Private placement \| Common Stock \| Pre-Funded Warrants
Class of Stock [Line Items]
Warrants, shares issued				2,585,963
Warrants, exercise price \| $ / shares				$ 0.0001
Securities Purchase Agreement and Warrants \| Private placement \| Common Stock \| Series E Warrants
Class of Stock [Line Items]
Warrants, shares issued				5,287,278
Warrants, exercise price \| $ / shares				$ 2.64
Warrants, exercisable term				5 years
Securities Purchase Agreement and Warrants \| Private placement \| Common Stock \| Common Shares and Series E Warrants
Class of Stock [Line Items]
Combined price per share of common stock and warrants \| $ / shares				$ 2.85
Securities Purchase Agreement and Warrants \| Private placement \| Common Stock \| Pre-funded and Series E Warrants
Class of Stock [Line Items]
Combined price per share of common stock and warrants \| $ / shares				$ 2.849
Term of 2024 Securities Purchase Agreement				1 year
Suspension period				15 days
Purchase agreement exclusivity period				60 days
Securities Purchase Agreement and Warrants \| Private placement \| Common Stock \| Pre-funded and Series E Warrants \| Maximum
Class of Stock [Line Items]
Warrant exercise, common stock ownership limitation				4.99%
Warrant exercise, common stock ownership limitation (at the election of the holder)				9.99%
Number of days to file a registration statement				75 days
Number of days to file a registration statement (in the event of a "full review" by SEC)				90 days
Securities Purchase Agreement and Warrants \| Private placement \| Common Stock \| Pre-funded and Series E Warrants \| Minimum
Class of Stock [Line Items]
Warrant holder's election, period of written notice				61 days
Number of days to file a registration statement				60 days
At Market Issuance Sales Agreement \| Placement Agents \| At-The-Market Offerings \| Common Stock
Class of Stock [Line Items]
Common stock, par value \| $ / shares														$ 0.001
Aggregate offering price \| $														$ 7,350,000
Common stock, shares issued											3,184,899
Net proceeds from sale of equity \| $											$ 2,617,000
2025 Purchase Agreement \| Investors \| Private placement \| Common Stock
Class of Stock [Line Items]
Common stock, shares issued		240,807
Share price on new issues \| $ / shares		$ 2.72
Aggregate gross proceeds \| $		$ 655,000
Gross proceeds from sale of equity \| $		$ 655,000
AstralBio Exclusive License Agreement
Class of Stock [Line Items]
Common stock, shares issued	246,087
Payment of upfront licensing fee \| $	$ 750,000
Warrants \| H.C. Wainwright & Co. \| Common Stock \| Pre-Funded Warrants
Class of Stock [Line Items]
Warrants, exercise price \| $ / shares																$ 0.001
Warrants \| H.C. Wainwright & Co. \| Common Stock \| Representative Warrants
Class of Stock [Line Items]
Warrants, exercise price \| $ / shares																$ 26
Warrants, exercisable term																5 years
Warrants \| H.C. Wainwright & Co. \| Common Stock \| Warrants
Class of Stock [Line Items]
Warrants, exercise price \| $ / shares															$ 10	$ 20.8
Warrants \| H.C. Wainwright & Co. \| Common Stock \| Series A warrants
Class of Stock [Line Items]
Warrants, shares of common stock issuable upon conversion															173,795
Warrants, exercise price \| $ / shares																$ 20.8
Warrants, exercisable term																5 years
Warrants \| H.C. Wainwright & Co. \| Common Stock \| Series B warrants
Class of Stock [Line Items]
Warrants, shares of common stock issuable upon conversion															102,900
Warrants, exercise price \| $ / shares																$ 20.8
Warrants, exercisable term																2 years
Warrants \| Bryan Capital \| Common Stock \| Warrants
Class of Stock [Line Items]
Warrants, shares issued									2,579
Warrants, exercise price \| $ / shares									$ 665
Warrants \| Alliance Global Partners \| Private placement \| Common Stock
Class of Stock [Line Items]
Common stock, shares issued					600,000
Warrants \| Alliance Global Partners \| Private placement \| Common Stock \| Pre-Funded Warrants
Class of Stock [Line Items]
Warrants, shares issued					1,650,000
Warrants, shares of common stock issuable upon conversion					1,650,000
Warrants, exercise price \| $ / shares					$ 0.0001
Combined price per share of common stock and warrants \| $ / shares					$ 1.9999
Warrants \| Alliance Global Partners \| Private placement \| Common Stock \| Series C Warrants
Class of Stock [Line Items]
Warrants, shares issued					2,250,000
Warrants, shares of common stock issuable upon conversion					2,250,000
Warrants, exercise price \| $ / shares					$ 2
Warrants, exercisable term					2 years
Warrants \| Alliance Global Partners \| Private placement \| Common Stock \| Series D Warrants
Class of Stock [Line Items]
Warrants, shares issued					2,250,000
Warrants, shares of common stock issuable upon conversion					2,250,000
Warrants, exercise price \| $ / shares					$ 2.00
Warrants, exercisable term					5 years